Save the Date!
2025 Clinical Outcome Assessment Program Annual Meeting
On April 9-10, 2025, the 2025 Clinical Outcome Assessment Program Annual Meeting will be held at the Bethesda North Marriott & Conference Center, Rockville, MD. Topics to be covered during this year’s event include:
- Update on FDA’s Clinical Outcome Assessment (COA) Qualification Program and other FDA initiatives
- The potential of AI for COA development and deployment in clinical trials
- Regulatory pathways for using patient experience data pre- and post-approval: navigating benefit-risk assessment and communications consistent with labeling
- Unique considerations for collection of clinical trial endpoints in rare diseases
- Generating patient-centered evidence that addresses regulatory, access, patient, and other stakeholder expectations: navigating a varied landscape
- Current thinking on the accessibility and burden of eCOA & DHT system use
- High-level summaries of the ongoing activities and recent accomplishments of the COA Program including updates from the PRO Consortium, Rare Disease COA Consortium, and eCOA Consortium
Registration: The registration fee will be $500/person* and registration will open in early January.
*Government employees, patients, patient representatives, and patient organization representatives will have the registration fee waived.
